ReviewCellular and molecular life sciences : CMLS2024

Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy.

Nasim Ebrahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.